IART
IART P/E Ratio
P/E Ratio as of Oct 28, 2026: 74.41
Average-66.42
Median-139.01
Minimum-175.34
Maximum81.76
74.41
245.85 (143.40%)past month
The P/E ratio for IART is 74.41 as of Oct 28, 2026. This represents a decrease of -262.25% compared to its 12-month average P/E ratio of -45.86. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Integra LifeSciences Holdings P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Integra LifeSciences Holdings’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Integra LifeSciences Holdings to industry peers.
Integra LifeSciences Holdings P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Integra LifeSciences Holdings’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Integra LifeSciences Holdings to industry peers.
IART P/E Ratio Insights
See Integra LifeSciences Holdings’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in IART
Order type
Buy in
Order amount
Est. shares
0 shares
IART P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2026 | $16.09 | -169.55 |
| Sep 1, 2026 | $16.62 | -175.13 |
| Aug 3, 2026 | $17.88 | -188.41 |
| Jul 1, 2026 | $17.89 | -2.77 |
| Jun 1, 2026 | $15.67 | -2.42 |
| May 1, 2026 | $10.95 | -1.63 |
| Apr 1, 2026 | $9.57 | -1.42 |
| Mar 2, 2026 | $10.43 | -1.55 |
| Feb 2, 2026 | $11.16 | -1.73 |
| Jan 2, 2026 | $12.01 | -1.86 |
IART End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | 74.41 | -3,975.52% |
| 2025 | -1.92 | -99.25% |
| 2024 | -254.55 | -814.83% |
| 2023 | 35.61 | +30.44% |
| 2022 | 27.30 | -19.37% |
| 2021 | 33.86 | — |
FAQs About Integra LifeSciences Holdings (IART) P/E ratio
The latest P/E ratio of IART is 74.41, as of Oct 28, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Integra LifeSciences Holdings’s last 12-month average P/E ratio is -45.86, compared to its current P/E ratio of 74.41. This reflects a decrease of -262.25%.
Integra LifeSciences Holdings’s current P/E ratio of 74.41 is lower than its last 12-month average P/E of -45.86. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Integra LifeSciences Holdings’s average P/E ratio over the last 3 years is -45.4. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Integra LifeSciences Holdings’s average P/E ratio over the last 5 years is -16.02. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
IART P/E Ratio Insights
See Integra LifeSciences Holdings’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in IART
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.